Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cascadian Therapeutics Inc (NASDAQ:CASC)

5.68
Delayed Data
As of Dec 08
 -0.23 / -3.89%
Today’s Change
4.89
Today|||52-Week Range
20.46
-57.36%
Year-to-Date

Today’s Trading

Previous close5.91
Today’s open5.92
Day’s range5.44 - 6.18
Volume390,694
Average volume (3 months)128,647
Market cap$133.3M
Dividend yield--
Data as of 12/08/2016

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)-62.01%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.70

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.50+13.40%
PRTOProteon Therapeutics...0.000.00%
ARWRArrowhead Pharmaceut...0.000.00%
CDXSCodexis Inc+0.20+4.12%
Data as of 12/08/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs